Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine

scientific article published in October 2004

Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1368-5031.2004.00295.X
P698PubMed publication ID15587768

P2093author name stringJones M
Loftus J
Savani N
Landy S
Shackelford S
P2860cites workIs menstrually associated migraine difficult to treat?Q33754145
P433issue10
P921main subjectmigraineQ133823
menstruationQ12171
P304page(s)913-919
P577publication date2004-10-01
P1433published inInternational Journal of Clinical PracticeQ15758177
P1476titleEfficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine
P478volume58

Reverse relations

cites work (P2860)
Q36638660A review of the use of frovatriptan in the treatment of menstrually related migraine
Q37897224Almotriptan for menstrually related migraine
Q37798757Are the current IHS guidelines for migraine drug trials being followed?
Q38927015Comparative tolerability of treatments for acute migraine: A network meta-analysis
Q45995793Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
Q35522772Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.
Q34890784Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan
Q46898774Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
Q64113943From investigational product to active reference: evolution of oral sumatriptan efficacy versus placebo for the treatment of acute migraine episodes and potential impact in comparative analyses
Q36052155Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study
Q37785552Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study
Q34338801Management of menstrual migraine: a review of current abortive and prophylactic therapies
Q85056313Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine
Q50047547Menstrual migraine: a review of current and developing pharmacotherapies for women
Q38237616Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment
Q36941893Menstrual migraine: clinical and therapeutical aspects
Q36153372Migraine treatment throughout the lifecycle
Q37363486Perimenstrual headache: treatment options
Q34623397Prevention and Treatment of Menstrual Migraine
Q39336473Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies
Q43265529Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks
Q39284852Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study
Q24203707Sumatriptan (oral route of administration) for acute migraine attacks in adults
Q38066258Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine
Q36305785The use of triptans in the management of menstrual migraine
Q39277602Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database.
Q38014363Treatment of perimenstrual migraine with triptans: an update
Q37248355Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan
Q51314345Treatment strategies for menstrually related migraine.
Q35692944Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis
Q46955158Triptans in the treatment of migraine: drug selection by means of the SOJA method

Search more.